Home
Conditions
Idiopathic Pulmonary Fibrosis

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

330 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT04968574

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: Research Site Liverpool, New South Wales, Australia

Research Site Benowa, Queensland, Australia

Research Site Box Hill, Victoria, Australia

Research Site Clayton, Victoria, Australia

View all 24 locations

View Trial Details

Completed

The First-in-human Study of SRN-001 in Healthy Participants

NCT05984992

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: CMAX Clinical Research Adelaide, South Australia, Australia

View Trial Details

Completed

All-Case Surveillance of Ofev in Patients With IPF in Japan

NCT02607722

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Multiple Locations, Japan

View Trial Details

Completed

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05870956

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Medicus Economics, LCC Milton, Massachusetts, United States

View Trial Details

Completed

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

NCT02315586

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

NCT06588517

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: The Affiliated Hospital of Qingdao University Qingdao, Shandong, China

View Trial Details

Completed

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

NCT06589921

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: The Affiliated Hospital of Qingdao University Qingdao, Shandong, China

View Trial Details

Completed

Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)

NCT03901196

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +10 more
Locations: Grenoble Alpes University Hospital Grenoble, France

CHRU de LILLE Lille, France

CHU de Lyon HCL - GH Sud Lyon, France

Hôpital Louis Pradel Lyon, France

View Trial Details

Completed

The Assessment of Nutritional Status of Patients With IPF

NCT06563011

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Atatürk Sanatorium Training and Research Hospital Ankara, Turkey (Türkiye)

View Trial Details

Completed

The Effect of N115 on Coughing in IPF Patients

NCT06037408

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Family First Medical Research Center Hialeah Gardens, Florida, United States

View Trial Details

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis trial results

Related conditions